NEOGENChemicals
Neogen Chemicals Limited
Current Priceโ‚น2,048.3(+1.19%)
Market Capโ‚น5,609 Cr
Analysis WindowQ1 FY27
Last Updated29 Jul 2026
Flagium AI Risk Score
Composite forensic risk score based on earnings quality, cash flow, and balance sheet signals. Lower is better.
37/ 100
Watchยท๐ŸŸขImproving (-8 QoQ)
Business๐ŸŸก Watch
Primary DriverWorking Capital Expansion
Valuationsโœ— Demanding
Implied Rev Gap+0.0%
Market Structureโœ“ Strong
Stage 219 sessions

Institutional accumulation regime. Strong business quality combined with supportive market trend. Valuations remain demanding and supported by current metrics.

Market Alignment
๐ŸŸ  MixedMarket behavior shows signs of strength while underlying fundamental risk is elevated.
Business37/100WatchQoQ Delta: -8 ptsRisk Trend: Improving
ValuationDemandingImplied 53.3% vs 7.9% ObservedValuation Risk: High
Market StructureStage 2 ยท Stage 2 โ€” AdvancingRegime Days: 19A/D Flow: Strong Distribution (-3.07ฯƒ)7D Ago Flow: โ€”

What Changed? THIS QUARTER

  • โœ“Risk score improved (QoQ change: -8 pts)
  • โœ—Profitability margins remain stressed
  • โœ—Growth expectations are demanding
  • โœ“Market structure is strong
  • โ—‹Institutional flow regime is Strong Distribution (-3.07ฯƒ)
  • โœ“Share price is up +1.2% this quarter (from โ‚น2,024.9 on 30 Jun to โ‚น2,048.3)

Divergence Radar

BUSINESS STRENGTH63/100
VALUATIONS SURVIVAL (CONSERVATISM)43/100
MARKET TREND STRUCTURE90/100
INSTITUTIONAL FLOW ACCUMULATION0/100

Structural Matrix

Valuation
Business Quality
Low
Balanced
High
Strong
Weak
๐Ÿ”ด

Risk vs Price Timeline
Visualizing the historical relationship between the structural risk score and stock price movement over time.

Loading Chart
Share Price
Risk Score (0-100)
Market Performance
โ‚น2,048.3(+1.19%)
1M Divergence+6.95%
DurationPerf.Sector AvgDivergence
1 Week-2.7%+0.6%-3.3%
1 Month+8.82%+1.87%+6.95%
6 Months+68.38%+17.92%+50.46%
1 Year+32.62%+5.56%+27.06%
2 Year+21.28%+9.22%+12.07%
3 Year+31.17%+82.5%-51.33%
๐Ÿ’ก

How to Read Business Analysis

Business analysis focuses on structural risk inside the company. Flagium monitors earnings quality, balance sheet strength, liquidity, governance, competitive position, and growth sustainability to identify areas where risk may be increasing or decreasing before it becomes obvious in reported results.

Flagium AI Risk Score37 / 100Riskier than 97.3% of Sector Peers
Risk ClassWatch
Risk Trend-8 QoQ ยท ImprovingRisk score improved (-8 pts)
Risk Acceleration+0 Qtrs
Escalation Prob.5%โœ… NEUTRAL
Interpretation

Financial profile remains stable for now. Pressure is receding in profitability and earnings quality. This suggests the risk profile is currently stabilizing. Risk levels are improving.

Risk Score Composition
Absolute point contribution of each forensic risk driver to the final composite risk score.

Earnings Quality
+7.9 pts
Balance Sheet Stress
+7.7 pts
Stability Adjustment
+21.0 pts
Final Composite Risk37 / 100

Investment Risk Thesis

Historical Trend

Current risk score has risen from 14 โ†’ 37 over 12 quarters.

Expected Direction
๐ŸŸข Improving
Primary Deterioration Drivers
  • Inventory Stress
  • Margin Compression
  • Industrial Margin Stress
What to Watch Next Quarter
  • Working capital efficiency
  • Inventory turnover
  • Operating profit margins

Risk Drivers (Active Warnings)

Liquidity & Coverage
โ– Working Capital Expansion
SEVEREDecaying
Earning Quality
โ– Inventory Stress
HIGHDecaying
โ– Profit Collapse
HIGHDecaying

Primary Driver & Insights

Key Contributor
Earning Quality
โ– Inventory StressHIGH
Forensic Analyst Insight

Asset turnover is slowing down due to inventory accumulation. This indicates potential channel stuffing or weaker demand in core product segments.

Advanced Business Analytics

Active Risk Objects (11)

CriticalHigh
Low Interest Coverage
๐Ÿ’ง Liquidity & CoverageQuarterlyActive for 11 Qtrs
Impact Weight8/15
MomentumPersistent
Last SignalQ1 FY2027
NEOGEN: Low Interest Coverage Ratio of 2.11x in FY2027 Q1 (Threshold: 2.5x).

"Earnings buffer for interest payments is narrowing. Monitor for margin pressure."

Inventory Stress
๐Ÿ“Š Earnings QualityAnnualActive for 2 Years
Impact Weight15/15
MomentumDecaying
Last SignalQ4 FY2026
Inventory growth (83.8%) significantly outpaced revenue growth (21.7%).

"Inventory overhang is clearing. Stock levels are normalizing as sales momentum returns."

Margin Compression
๐Ÿ“Š Earnings QualityAnnualActive for 2 Years
Impact Weight15/15
MomentumDecaying
Last SignalQ4 FY2026
Operating margin declined by 2.3 bps YoY for two consecutive quarters.

"Operating efficiency is stabilizing. The rate of margin deterioration has slowed."

Industrial Margin Stress
๐Ÿ“‰ Trend DeteriorationAnnualActive for 5 Years
Impact Weight12/15
MomentumPersistent
Last SignalQ1 FY2027
NEOGEN: Raw material costs consumed an additional 4.3% of revenue YoY.

"Early signs of margin erosion. Input costs are beginning to eat into core profits."

๐ŸŸก HighRelative Growth Weakness
Q3 FY2026
Show Analysis
๐ŸŸก HighWorking Capital Expansion
Q4 FY2026
Show Analysis
๐ŸŸก HighOperating Leverage Stress
Q3 FY2026
Show Analysis
๐ŸŸก HighProfit Collapse
Q3 FY2026
Show Analysis
๐ŸŸก HighCapex Efficiency Stress
Q2 FY2026
Show Analysis
๐ŸŸก HighNegative FCF Streak
FY2026
Show Analysis
๐ŸŸก HighCash Conversion Deficit
FY2026
Show Analysis
Risk Trajectory
Historical 12-quarter risk trend (Q-11 to Q0) followed by a 2-quarter predictive funnel (Q+1, Q+2).
Loading Chart
Business Stability
Key indicators of structural risk, cash buffer capability, and risk progression.
Shock ResistanceLow
Escalation RiskLow
Financial StabilityHigh
Margin of SafetyHigh
Forensic Benchmark Context: Chemicals (n=126 peers)

Business Resilience & Benchmark Context

Overall: HEALTHY
Solvency(10)Excellentโ˜…โ˜…โ˜…โ˜…โ˜…
โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ100th %ile
Governance(10)Excellentโ˜…โ˜…โ˜…โ˜…โ˜…
โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ100th %ile
Earnings Quality(4.7)Weakโ˜…โ˜…โ˜†โ˜†โ˜†
โ–ˆโ–ˆโ–‘โ–‘โ–‘47th %ile
Balance Sheet Stress(6.2)Fairโ˜…โ˜…โ˜…โ˜†โ˜†
โ–ˆโ–ˆโ–ˆโ–‘โ–‘62th %ile
Competitive Position(10)Excellentโ˜…โ˜…โ˜…โ˜…โ˜…
โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ100th %ile
Growth Sustainability(10)Excellentโ˜…โ˜…โ˜…โ˜…โ˜…
โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ100th %ile

Deterioration Timeline

2027

Industrial Margin Stress

2026

Industrial Margin Stress

2026

Margin Compression

2026

Working Capital Expansion

2026

Inventory Stress

2026

Operating Leverage Stress

2026

Margin Compression

2026

Relative Growth Weakness

2026

Industrial Margin Stress

2026

Relative Growth Weakness

2026

Industrial Margin Stress

2026

Operating Leverage Stress

2026

Capex Efficiency Stress

2026

Operating Leverage Stress

2026

Cash Conversion Deficit

2026

Negative FCF Streak

2025

Industrial Margin Stress

2025

Cash Conversion Deficit

2025

Negative FCF Streak

2024

Working Capital Expansion

2024

Inventory Stress

2024

Working Capital Expansion

2024

Negative FCF Streak

2024

Cash Conversion Deficit

Key Financials (INR Cr)

Revenue Trend
Growingโ†‘
Profitability
Improvingโ†‘
Cash Generation
Weakeningโ†“
Debt Trend
Risingโ†‘
PeriodRevenueEBITDANet ProfitCFODebt
FY202686814429-2311,330
FY202578212635196566
FY202469811836-29394
FY202369111650-30362
FY202248888451-
3Y Growth Snapshot+26%+24%-42%-663%+267%
Sentinel Forensic AssessmentALGORITHMIC RISK PROFILE โ€ข NON-ADVISORY
Fundamental Status

Business quality remains stable.

Forensic Pressure

Current forensic pressure is elevated and improving.

Primary Risk Vectors

Key risks remain concentrated in growth sustainability and operating leverage.

The risk profile is Early Signals and currently improving. Recent structural triggers in earnings quality suggest a building pressure on the underlying framework. Material forensic traces are visible in operational margins and profitability metrics, indicating a progressive erosion of structural stability. Initial structural recovery is visible; monitor for a sustained return to resilience.

MARKET EXPECTATION ENGINE
DEMANDING EXPECTATIONS
๐Ÿ’ก

How to read this

We calculate the future growth rate the market is currently expecting and compare it to the company's historical delivery. A higher required growth target indicates more demanding market expectations and elevated expectation risk.

Sentinel InsightsThe market expects future growth significantly above the company's historical delivery. Current market expectations appear demanding relative to the business's track record, resulting in higher expectation risk.

Implied Revenue CAGR53.3%Future Growth Needed
Observed Revenue CAGR7.9%Actual Past Growth
Revenue Growth Gap+45.3%Growth Jump Needed
Expectation Risk Score95/100Price Risk Score
CONSERVATIVE (-7%)BALANCEDDEMANDING (55%)
Historical (7.9%)
Market (53.3%)
Valuation Summary

Using the Implied Revenue Model, the market is pricing NEOGEN for 53.3% implied revenue growth versus 7.9% observed 3Y revenue CAGR. Current expectations appear demanding, and trailing fundamentals provide moderate support.

Business Delivery Capacity

Performance quality vs historical benchmarks
Historical Delivery Audit
Revenue Growth SupportObserved CAGR vs cost of capital baseline
7.9% CAGR
โœ“ Achieved
Operating Profitability SupportEBIT margins compared to historical standards
6.8% Margin
โœ— Weak Margin
Cash Flow Generation SupportOperating cash flow conversion and support cushion
-912.4% Conv
โœ— Negative
Capital Leverage RiskLeverage indicators and solvency pressure
Pressure
โœ— Leverage Risk
Delivery Capacity Index
25/100
LOW CAPACITY

Historical business performance currently provides limited support for the market's implied growth assumptions. Improvement in revenue growth and operating efficiency would strengthen expectation support.

WHY IS EXPECTATION RISK ELEVATED?

Risk Drivers:
โœ“High implied growth
โœ“Expensive valuation regime
โœ“Weak profitability support
โœ“Weak cash generation support

Valuation Context

Historical Valuation59th percentile
Cash Yield Support-14.03% (Weak)
Sector Premium+192% EV/EBITDA
Current Valuation RegimeDemanding

WHAT MUST HAPPEN FOR CURRENT PRICE TO BE CORRECT?

MARKET REQUIRED METRICS
Assumption MetricRequired (To justify current price)Historical Delivery (Average)Fulfillment Assessment
Revenue Growth (CAGR)53.3%7.9%Aggressive
Operating Margin (EBIT)5.3%6.8%Achievable
Free Cash Flow Conversion-1585.7%-912.4%Achievable

*Required metrics indicate the operating efficiency and revenue expansion parameters that must be sustained long-term to justify the current stock price.

Advanced Valuation Analytics
Sentinel Expectation Assessment

The current valuation assumes business performance well above the company's historical record. Historical operating performance currently provides limited evidence that these expectations are sustainable. Continued stronger profitability and stronger cash generation would be required to justify current pricing.

๐Ÿ’ก

How to read Market Structure

Flagium separates Business Risk from Market Structure. Business analysis explains what is happening inside the company. Market Structure measures how investors are behaving through price trends, momentum, participation, and institutional activity. Divergences between the two often reveal important transitions before they become obvious.

Market Structure
STAGE 2
ADVANCINGGROWTH CYCLE
Stage Progress
Measures the progress of the stock's current price, volume, and momentum characteristic alignments.
81%
TrendAdvancing
MomentumNeutral
ParticipationNeutral
A/D FlowDeteriorating
Sentinel Market Insight

The stock remains in a confirmed Stage 2 advancing phase. Although institutional participation has weakened, trend quality remains constructive while momentum is accelerating. Current price action continues to support the prevailing advance.

What Is Driving Market Structure?

Market Drivers
โœ“Long-term trend remains above the 150DMA
โœ“Long-term trend remains above the 200DMA
โœ“RS continues to lead the market
โœ—Institutional flow has deteriorated
โœ“Momentum remains positive
Summary
๐ŸŸ Mixed

Market behavior shows signs of strength while underlying fundamental risk is elevated.

Weinstein Stage Analysis

S1
Accumulation
S2
Advancing
S3
Distribution
S4
Declining
Stage Lifecycle
Stage Progress
81%
Readiness LabelHigh (Phase Transition Imminent)
Regime Sessions19 Sessions
Transition Probability96% High
Measures the alignment and consistency of the stock's price trend relative to its historical volume volatility.
1.2983ฯƒ Healthy
Trend & Strength
Trend QualityStrong
150 DMA Slope+9.2404%
Participation & Volume
Avg Turnover (200D)โ‚น22.8 Cr
Liquidity RatingIlliquid โ€” Avoid
ParticipationHealthy

Momentum & Institutional Flow

Price Momentum
Momentum StrengthImproving momentum strength
Price momentum score in standard deviations (ฯƒ). Readings beyond ยฑ2.0ฯƒ indicate extreme momentum shifts.
+0.4469ฯƒ
Universe Rank
#459 of 2791Top 16.45% in momentum strength
Institutional Accumulation
21D Flow Score
21-day cumulative institutional flow score in standard deviations (ฯƒ).
-3.07ฯƒ
7D Flow TrendDeteriorating
NEOGEN

Market Structure Analysis

Explore how each market indicator contributes to the current stage classification.

No market structure history available.
Methodology & Disclaimer

These analytics are derived from quantitative analysis of historical price, volume, and market participation data and are intended solely for informational and research purposes. They do not constitute investment advice, recommendations, or guarantees of future performance.